Genetic Testing Market Size By Test Type (Predictive Testing, Carrier Testing, Prenatal and New-born Testing, Diagnostic Testing, Pharmacogenomic Testing, Nutrigenomic Testing), By Application (Cancer, Genetic Disease, Cardiovascular Disease) Forecast, 2021 – 2026

Published: NOV 2020  |  Report ID: 071  | Pages: 150

Genetic Testing Market Value and Growth Analysis (2021-2026):

Genetic Testing Market Has Demonstrated Promising Development In The New Past. It Is Developing At A CAGR Of 8.85% From 2020 To 2025.

Genetic testing is conspicuous in getting the data of DNA from the clients and offers numerous treatment systems to the patient with the subtleties got from their lineage. According to the Planet Wellbeing Association, around 10,000 sicknesses are monogenic around the world. To stop and analyze these issues, one needs to change or transform one quality in each cell of the body, utilizing genetic testing. The U.S. government has affirmed a pre-implantation analysis for in vitro incipient organisms. These activities focus on the location and minimization of genetic irregularities influencing pre-implantation undeveloped organisms and, accordingly, the presence of administrative organizations like the Japanese Society of Obstetrics and Gynecology (JSOG).

Genetic Testing Market Segmentation:

By Type:

  • Carrier Testing
  • Prenatal Testing
  • Diagnostic Testing
  • Neonatal Testing

By Application:

  • Cancer Testing
  • Pharmacogenomics Testing
  • Prenatal Testing
  • Predisposition Testing

Genetic Testing Market Regional Analysis:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

The genetic testing market is overwhelming the most noteworthy portions of the worldwide market because of the line choice of the most recent innovation. The dispatch of creative demonstrative strategies with new innovation is growing the market interest in this locale. Additionally, expanding capital pay in both created and non-industrial nations are utilizing the market’s development rate.

The genetic testing market in Europe is situated second in holding the main portions of the market. The ascent popular for successful treatment techniques and furthermore developing mindfulness over the anticipation of the illnesses through DNA data from heritage is step up the development pace of the market. Expanding support from the public authority in presenting repayment plans for standard individuals is heightening the market’s development.

Asia Pacific genetic testing market is represented in having the quickest development rate from the previous decade and hit the most elevated CAGR in the coming years. The expanding old populace is an essential factor for the market to fill in this area. Furthermore, the developing predominance of the most recent hardware in examination communities supports the interest of the market.

Genetic Testing Market Key players:

  1. Abbott Laboratories
  2. Roche Molecular Diagnostics, Inc
  3. Abbott Molecular Inc
  4. Auto Genomics, Inc
  5. Celera Group
  6. ELITech Group
  7. BioRad Laboratories
  8. PerkinElmer Inc
  9. Roche Diagnostics Corp
  10. Quest Diagnostics Inc
  11. Transgenomic Inc
  12. Applied Biosystems, Inc

          1. Preface                      

                   1.1 Market Definition and Scope               

                   1.2 Base Currency, Base Year and Forecast Periods           

                   1.3 Key Research Objectives           

                   1.4 Research Highlights                  

          2. General Study Assumptions                           

          3. Research Methodology                         

                   3.1 Introduction            

                   3.2 Secondary Research                  

                   3.3 Primary Research             

                   3.4 Analysis Design               

                   3.5 Study Timeline                 

          4. Market Dynamics                         

                   4.1 Drivers          

                   4.2 Restraints               

                   4.3 Opportunities                   

                   4.4 Market Trends                 

          5. Supply Chain Analysis                          

          6. Company Strategy Analysis                            

                   6.1 Merger and Acquisition Analysis                 

                   6.2 Agreements, Collaborations and Joint Ventures           

                   6.3 Regional Presence           

                   6.4 New Product Launches              

          7. Market Outlook                            

                   7.1 Technological Advancement              

                   7.2 Pricing Analysis               

                   7.3 Epidemiology                   

                   7.4 Product Landscape Analysis (Brand Tracking Analysis & Pipeline Analysis)                   

          8. Market Segmentation                            

                   8.1 Overview                 

                   8.2 Global AI In Drug Discovery Market, By Technology, forecast year 2021-2026          

                             8.2.1 Deep Learning    

                             8.2.2 Machine Learning         

                             8.2.3 Market Size Estimations & Forecasts (2021-2026)

                             8.2.4 Y-o-Y Growth Analysis 

                             8.2.5 Market Investment Opportunities Analysis     

                   8.3 Global AI In Drug Discovery Market, By Drug Type, forecast year 2021-2026          

                             8.3.1 Small Molecule    

                             8.3.2 Large Molecules  

                             8.3.3 Market Size Estimations & Forecasts (2021-2026) 

                             8.3.4 Y-o-Y Growth Analysis 

                             8.3.5 Market Investment Opportunities Analysis     

                   8.4 Global AI In Drug Discovery Market, By Therapeutic Type, forecast year 2021-2026                   

                             8.4.1 Metabolic Disease        

                             8.4.2 Cardiovascular Disease          

                             8.4.3 Oncology    

                             8.4.4 Neurodegenerative Diseases          

                             8.4.5 Others        

                             8.4.6 Market Size Estimations & Forecasts (2021-2026)    

                             8.4.7 Y-o-Y Growth Analysis 

                             8.4.8 Market Investment Opportunities Analysis     

                   8.5 Global AI In Drug Discovery Market, By End-Users, forecast year 2021-2026          

                             8.5.1 Pharmaceutical Companies   

                             8.5.2 Biopharmaceutical Companies        

                             8.5.3 Academic and Research Institutes 

                             8.5.4 Others        

                             8.5.5 Market Size Estimations & Forecasts (2021-2026)    

                             8.5.6 Y-o-Y Growth Analysis 

                             8.5.7 Market Investment Opportunities Analysis     

          9. Market Regional and Country Analysis, Forecast 2021-2026 

                   9.1 Overview                 

                   9.2 Regional Trends              

                   9.3 Impact Analysis                

                   9.4 Key Findings           

                   9.5 Global AI In Drug Discovery Market,  by Region, 2021-2026                   

                             9.5.1 By Technology     

                             9.5.2 By Drug Type      

                             9.5.3 By Therapeutic Type    

                             9.5.4 By End-Users      

          10. Competitive Landscape Analysis                           

                   10.1 Market Player                 

                             10.1.1 Company Revenue     

                             10.1.2 Business unit    

                             10.1.3 Product Mapping        

                             10.1.4 Geographical Locations       

                   10.2 Company Share Analysis                  

          11. Strategic Analysis                      

                   11.1 PESTLE analysis              

                   11.2 Porter’s Five analysis               

                             11.2.1 Bargaining Power of Suppliers      

                             11.2.2 Bargaining Power of Consumers   

                             11.2.3 Threat of New Entrants        

                             11.2.4 Threat of Substitute Products and Services   

                             11.2.5 Competitive Rivalry within the Industry 

          12. Company Profiles                      

                   12.1 IBM Corporation             

                             12.1.1 Overview  

                             12.1.2 Product Portfolio         

                             12.1.3 Financial Details         

                             12.1.4 SWOT Analysis  

                             12.1.5 Market Strategies       

                   12.2 Microsoft              

                   12.3 Atomwise Inc                 

                   12.4 Deep Genomics             

                   12.5 Cloud Pharmaceuticals           

                   12.6 Insilico Medicine           

                   12.7 Benevolent AI                 

                   12.8 Exscientia             

                   12.9 Cyclica                  

                   12.10 BIOAGE               

          13. Market Guidance                       

          14. Appendix                        

Note: Information provided by you stored on our secure servers. We Protect Your Privacy.